In samples of prostate cancer with an ERG translocation, 40 known and 15 unknown metabolites were found to be increased and 15 known and two unknown metabolites were found to be decreased in comparison to ERG-negative carcinomas (Table 2, Table 3B). Here, ERG is linked to prostate carcinoma.